Zacks Investment Research on MSN
Beam Therapeutics stock soars 21% in three months: Here's why
Shares of Beam Therapeutics BEAM have risen 21% over the past three months against the industry’s 4.5% decline, primarily ...
On May 18, 2026, Beam Therapeutics Inc. (NASDAQ:BEAM) presented updated Phase 1/2 data for BEAM-302 in alpha-1 antitrypsin ...
Beam Therapeutics (BEAM) is at the forefront of gene editing, a revolutionary medical technology that is drawing significant interest from investors worldwide due to its immense potential for treating ...
A chilled beam is an air distribution device with an integral coil that may be installed within a space in order to provide sensible cooling and heating. There are two main types of chilled beams: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results